BAT Senior Executives Acquire Shares Through Dividend Reinvestment Plans
Chief Executive Tadeu Marroco and ten other senior managers added shares through the company's incentive schemes in mid-August.
Senior Management Increases Stakes
British American Tobacco p.l.c. disclosed multiple insider transactions involving Chief Executive Tadeu Marroco and ten other senior executives through the company's share incentive programs, according to regulatory filings submitted August 18, 2026.
The transactions occurred through two separate mechanisms: the British American Tobacco Share Incentive Plan and the Deferred Share Bonus Scheme, both of which automatically reinvest dividends into additional company shares (6-K filing, 2026-08-18).
Dividend Reinvestment Transactions
On August 14, 2026, eleven senior managers acquired shares at £42.1532 through the Share Incentive Plan's dividend reinvestment feature (6-K filing, 2026-08-18). Chief Executive Tadeu Marroco acquired 40 shares, representing the largest volume among the disclosed transactions. Johan Vandermeulen, Chief Operating Officer, acquired 35 shares, while Fred Monteiro, Regional Director for Americas & Europe, acquired 27 shares.
Other participants included David Waterfield, President and CEO of Reynolds American Inc. (25 shares); James Murphy, Director of Research and Science (21 shares); Paul McCrory, Director of Legal and General Counsel (19 shares); and Luciano Comin, Chief Marketing Officer (19 shares). Kingsley Wheaton, Chief Corporate Officer, acquired 10 shares, while both Javed Iqbal, Interim Chief Financial Officer, and Zafar Khan, Director of Operations, each acquired 9 shares. Cora Koppe-Stahrenberg, Chief People Officer, acquired 2 shares (6-K filing, 2026-08-18).
All dividend reinvestment transactions were executed on the London Stock Exchange under the ticker XLON (6-K filing, 2026-08-18).
Deferred Bonus Scheme Activity
Separately, Chief Executive Marroco acquired additional shares on August 17, 2026, through the British American Tobacco Deferred Share Bonus Scheme (6-K filing, 2026-08-18). These were described as "quarterly dividend equivalent shares" and were acquired outside a trading venue, though specific volume and pricing details were not disclosed in the filing.
Broader Context
The filings were submitted by Nancy Jiang, the officer responsible for regulatory notifications at British American Tobacco (6-K filing, 2026-08-18). All transactions involved ordinary shares with a nominal value of 25 pence each, identified by ISIN GB0002875804.
According to MarginX data, British American Tobacco has been conducting regular share buyback programs, with recent repurchases of 128,513 shares, 130,513 shares, and 128,629 shares. The company has an upcoming cash dividend of £0.6126 scheduled for October 1, 2026, and will host an Analyst/Investor Day on September 29-30, 2026.
The £121 billion market capitalization company closed at $41.47 in its most recent trading session. The disclosed transactions represent routine insider activity through established employee incentive programs rather than discretionary market purchases by executives.
Regulatory Compliance
The disclosures fulfill UK regulatory requirements for persons discharging managerial responsibilities to notify markets of transactions in company securities. British American Tobacco's Legal Entity Identifier (LEI) is 213800FKA5MF17RJKT63 (6-K filing, 2026-08-18).
This article was generated by MarginX from the 6-K filing on 2026-08-18. It is not investment advice.